Biomarkers for dementia in Latin American countries: Gaps and opportunities
No hay miniatura disponible
Archivos
Fecha
2023-02
Profesor/a Guía
Facultad/escuela
Idioma
en
Título de la revista
ISSN de la revista
Título del volumen
Editor
John Wiley and Sons Inc
Nombre de Curso
Licencia CC
CC BY-NC 4.0 Attribution-NonCommercial 4.0 International Deed
Licencia CC
https://creativecommons.org/licenses/by-nc/4.0/
Resumen
Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC) countries remains a serious barrier. Here, we reported a survey to explore the ongoing work, needs, interests, potential barriers, and opportunities for future studies related to biomarkers. The results show that neuroimaging is the most used biomarker (73%), followed by genetic studies (40%), peripheral fluids biomarkers (31%), and cerebrospinal fluid biomarkers (29%). Regarding barriers in LAC, lack of funding appears to undermine the implementation of biomarkers in clinical or research settings, followed by insufficient infrastructure and training. The survey revealed that despite the above barriers, the region holds a great potential to advance dementia biomarkers research. Considering the unique contributions that LAC could make to this growing field, we highlight the urgent need to expand biomarker research. These insights allowed us to propose an action plan that addresses the recommendations for a biomarker framework recently proposed by regional experts. © 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Notas
Indexación: Scopus.
Palabras clave
Dementia, Humans, Latin America
Citación
Alzheimer's and Dementia. Volume 19, Issue 2, Pages 721 - 735. February 2023
DOI
10.1002/alz.12757